Charles Schwab Investment Management Inc. Raises Stock Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Charles Schwab Investment Management Inc. lifted its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 2.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 474,257 shares of the company’s stock after buying an additional 11,390 shares during the period. […]
Charles Schwab Investment Management Inc. lifted its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 2.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 474,257 shares of the company’s stock after buying an additional 11,390 shares during the period. […]
